Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study

Journal of General Internal Medicine

Volumn 30, Issue 10, 2015, Pages 1421-1425

  Roper, Nitin ^a   Korenstein, Deborah ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

conflict of interest; guest authorship; honorary authorship; industry collaboration; industry funding; primary guest authorship

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDY; FUNDING; HUMAN; PUBLIC-PRIVATE PARTNERSHIP; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; WRITING; COOPERATION; DRUG INDUSTRY; ECONOMICS; INTERPERSONAL COMMUNICATION; PUBLISHING; STANDARDS;

AUTHORSHIP; CONFLICT OF INTEREST; COOPERATIVE BEHAVIOR; CROSS-SECTIONAL STUDIES; DISCLOSURE; DRUG INDUSTRY; EDITORIAL POLICIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84942499745     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3299-1     Document Type: Article

References (14)

1. PLOS Medicine: Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles. Available at: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001070. Accessed March 6, 2015.
2. Mowatt G, Shirran L, Grimshaw JM, et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002;287(21):2769–71. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12038907. Accessed March 6, 2015.
3. Shapiro DW, Wenger NS, Shapiro MF. The contributions of authors to multiauthored biomedical research papers. JAMA. 1994;271(6):438–42. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8295318. Accessed March 6, 2015.
4. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9676661. Accessed March 6, 2015.
5. Wislar JS, Flanagin A, Fontanarosa PB, Deangelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ. 2011;343:d6128. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3202014&tool=pmcentrez&rendertype=abstract. Accessed March 6, 2015.
6. International Committee of Medical Journal Editors. ICMJE recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals. 2013. Available at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. Accessed March 6, 2015
7. Section 801 Food and Drug Administration Amendments Act of 2007. Washington, DC Available at: http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf. Accessed March 6, 2015
8. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299(15):1800–12. doi:10.1001/jama.299.15.1800.
9. Roper N, Zhang N, Korenstein D. Industry collaboration and randomized clinical trial design and outcomes. JAMA Intern Med. 2014;174(10):1695–6. doi:10.1001/jamainternmed.2014.3590.
10. Holmes DR, Hodgson PK, Nishimura RA, Simari RD. Manuscript preparation and publication. Circulation. 2009;120(10):906–13. doi:10.1161/CIRCULATIONAHA.107.752782.
11. Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals. Mayo Clin Proc. 2009;84(9):811–21. doi:10.1016/S0025-6196(11)60491-6.
12. Chaudhry S, Schroter S, Smith R, Morris J. Does declaration of competing interests affect readers’ perceptions? A randomised trial. BMJ. 2002;325(7377):1391–2. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138516&tool=pmcentrez&rendertype=abstract. Accessed March 6, 2015.
13. Meilof JF, Hylkema MN. The Lancet and advertorials. Lancet. 2009;373(9668):1004. doi:10.1016/S0140-6736(09)60600-0. author reply 1004–5.
14. Smith R, Gøtzsche PC, Groves T. Should journals stop publishing research funded by the drug industry? BMJ. 2014;348:g171. doi:10.1136/bmj.g171.